Ingrid Choong - 30 Aug 2023 Form 3 Insider Report for Eiger BioPharmaceuticals, Inc.

Reporting relationship: Chief Business Officer
Issuer ticker: N/A
Reported as of: 30 Aug 2023
Net transaction value: $0
SEC form: 3
Accepted by SEC: 05 Sep 2023, 21:35:36 UTC
Next SEC filing: 05 Sep 2023
Source filing: View source filing
Reporting owner signature: /s/ James Vollins, Attorney-in-Fact for Ingrid C. Choong

Key filing fact

Ingrid Choong filed Form 3 for Eiger BioPharmaceuticals, Inc. on 05 Sep 2023.

Key facts

This page summarizes Ingrid Choong's Form 3 filing for Eiger BioPharmaceuticals, Inc..
0 reported transactions and 12 derivative rows are listed below.
Accepted by SEC: 05 Sep 2023, 21:35.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EIGR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 31,100
Date: 30 Aug 2023
Ownership: Direct
Footnotes: F1

EIGR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,400
Date: 30 Aug 2023
Ownership: By Family Trust
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EIGR holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,251
Exercise price: $1.37
Footnotes: F3

EIGR holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,490
Exercise price: $15.89
Footnotes: F3

EIGR holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,200
Exercise price: $11.75
Footnotes: F3

EIGR holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,000
Exercise price: $9.50
Footnotes: F3

EIGR holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,500
Exercise price: $14.31
Footnotes: F3

EIGR holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $10.25
Footnotes: F4

EIGR holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,000
Exercise price: $5.60
Footnotes: F5

EIGR holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 60,000
Exercise price: $9.99
Footnotes: F6

EIGR holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,500
Exercise price: $8.15
Footnotes: F7

EIGR holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 98,000
Exercise price: $5.10
Footnotes: F8

EIGR holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,750
Exercise price: $1.37
Footnotes: F9

EIGR holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 98,000
Exercise price: $1.71
Footnotes: F10

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

Includes 3,333 shares underlying Restricted Stock Units ("RSUs") award that will vest in three equal annual installments measured from March 12, 2021, and 10,666 shares underlying RSUs award that will vest in three equal annual installments measured from March 11, 2022.

Footnote F2

These shares are held directly by the Choong-Dragoli Family Trust, for which the Reporting Person serves as co-trustee.

Footnote F3

These options are fully vested.

Footnote F4

The option vests in equal installments over 48 months measured from September 30, 2019, subject to the Reporting Person's continuous service as of each such date.

Footnote F5

The option vests in equal installments over 48 months measured from March 12, 2020, subject to the Reporting Person's continuous service as of each such date.

Footnote F6

The option vests in equal installments over 48 months measured from March 12, 2021, subject to the Reporting Person's continuous service as of each such date.

Footnote F7

The option vests in equal installments over 36 months measured from July 29, 2021, subject to the Reporting Person's continuous service as of each such date.

Footnote F8

The option vests in equal installments over 48 months measured from March 11, 2022, subject to the Reporting Person's continuous service as of each such date.

Footnote F9

The option vests as to 50% on the first anniversary of the January 26, 2023 grant date, and as to the remaining 50% on June 26, 2024, subject to the Reporting Person's continuous service as of each such date. The option vests in full upon a change in control of the Issuer.

Footnote F10

The option vests in equal installments over 48 months measured from March 1, 2023, subject to the Reporting Person's continuous service as of each such date.

SEC remarks

Exhibit List: Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .